BackAVEO Pharmaceuticals Overview

AVEO Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for AVEO.

Quarterly Cost of Revenue

$3.96M
↑ 127.29% YoY

As of Sep 30, 2022

Annual Cost of Revenue (TTM)

$11.50M
↑ 325.15% YoY

Trailing 12 months ending Sep 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin